These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 19528788

  • 1. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.
    Murakami T, Eda Y, Nakasone T, Ami Y, Someya K, Yoshino N, Kaizu M, Izumi Y, Matsui H, Shinohara K, Yamamoto N, Honda M.
    AIDS; 2009 Jul 31; 23(12):1485-94. PubMed ID: 19528788
    [Abstract] [Full Text] [Related]

  • 2. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
    McCormick-Davis C, Dalton SB, Hout DR, Singh DK, Berman NE, Yong C, Pinson DM, Foresman L, Stephens EB.
    Virology; 2000 Jun 20; 272(1):112-26. PubMed ID: 10873754
    [Abstract] [Full Text] [Related]

  • 3. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M.
    J Med Virol; 2004 Jul 20; 73(3):368-77. PubMed ID: 15170630
    [Abstract] [Full Text] [Related]

  • 4. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
    Maggiorella MT, Baroncelli S, Michelini Z, Fanales-Belasio E, Moretti S, Sernicola L, Cara A, Negri DR, Buttò S, Fiorelli V, Tripiciano A, Scoglio A, Caputo A, Borsetti A, Ridolfi B, Bona R, ten Haaft P, Macchia I, Leone P, Pavone-Cossut MR, Nappi F, Ciccozzi M, Heeney J, Titti F, Cafaro A, Ensoli B.
    Vaccine; 2004 Sep 03; 22(25-26):3258-69. PubMed ID: 15308348
    [Abstract] [Full Text] [Related]

  • 5. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.
    Goldstein S, Ourmanov I, Brown CR, Plishka R, Buckler-White A, Byrum R, Hirsch VM.
    J Virol; 2005 Apr 03; 79(8):5153-62. PubMed ID: 15795299
    [Abstract] [Full Text] [Related]

  • 6. Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.
    Nishimura Y, Igarashi T, Buckler-White A, Buckler C, Imamichi H, Goeken RM, Lee WR, Lafont BA, Byrum R, Lane HC, Hirsch VM, Martin MA.
    J Virol; 2007 Jan 03; 81(2):893-902. PubMed ID: 17093193
    [Abstract] [Full Text] [Related]

  • 7. Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy.
    Verhoeven D, Sankaran S, Dandekar S.
    J Med Primatol; 2007 Aug 03; 36(4-5):219-27. PubMed ID: 17669210
    [Abstract] [Full Text] [Related]

  • 8. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R, Srivastava IK, Kuller L, Zarkikh I, Kraft Z, Fagrouch Z, Letvin NL, Heeney JL, Barnett SW, Stamatatos L.
    Virology; 2006 Jun 05; 349(2):276-89. PubMed ID: 16527321
    [Abstract] [Full Text] [Related]

  • 9. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K, Xin KQ, Ami Y, Izumi Y, Mizuguchi H, Ohta S, Yamamoto N, Honda M, Okuda K.
    Virology; 2007 Oct 25; 367(2):390-7. PubMed ID: 17628628
    [Abstract] [Full Text] [Related]

  • 10. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G.
    J Immunol; 2009 Jul 01; 183(1):706-17. PubMed ID: 19542473
    [Abstract] [Full Text] [Related]

  • 11. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM, Lu W.
    J Intern Med; 2007 Feb 01; 261(2):123-31. PubMed ID: 17241177
    [Abstract] [Full Text] [Related]

  • 12. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F.
    J Med Primatol; 2007 Aug 01; 36(4-5):180-94. PubMed ID: 17669207
    [Abstract] [Full Text] [Related]

  • 13. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN, Adams DR, Bashirian S, Butera S, Folks TM, Otten RA.
    J Med Primatol; 2006 Aug 01; 35(4-5):210-6. PubMed ID: 16872284
    [Abstract] [Full Text] [Related]

  • 14. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR, Gomez ML, Pacyniak E, Gomez LM, Fegley B, Mulcahy ER, Hill MS, Culley N, Pinson DM, Nothnick W, Powers MF, Wong SW, Stephens EB.
    Virology; 2006 Jan 20; 344(2):541-59. PubMed ID: 16199074
    [Abstract] [Full Text] [Related]

  • 15. Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.
    Eda Y, Murakami T, Ami Y, Nakasone T, Takizawa M, Someya K, Kaizu M, Izumi Y, Yoshino N, Matsushita S, Higuchi H, Matsui H, Shinohara K, Takeuchi H, Koyanagi Y, Yamamoto N, Honda M.
    J Virol; 2006 Jun 20; 80(11):5563-70. PubMed ID: 16699037
    [Abstract] [Full Text] [Related]

  • 16. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS, Park KS, Sauermann U, Kim KS, Ahn SS, Franz M, Schulte R, Wilfingseder D, Stoiber H, Uberla K, Hunsmann G, Stahl-Hennig C, Sung YC.
    Vaccine; 2008 Dec 02; 26(51):6690-8. PubMed ID: 18694796
    [Abstract] [Full Text] [Related]

  • 17. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R.
    Vaccine; 2008 Jan 24; 26(4):532-45. PubMed ID: 18093703
    [Abstract] [Full Text] [Related]

  • 18. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.
    Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP.
    Nat Med; 2003 Mar 24; 9(3):343-6. PubMed ID: 12579198
    [Abstract] [Full Text] [Related]

  • 19. Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus.
    Miyake A, Ibuki K, Suzuki H, Horiuchi R, Saito N, Motohara M, Hayami M, Miura T.
    J Med Primatol; 2005 Oct 24; 34(5-6):294-302. PubMed ID: 16128924
    [Abstract] [Full Text] [Related]

  • 20. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A, Baroncelli S, Maggiorella MT, Bellino S, Moretti S, Sernicola L, Belli R, Ridolfi B, Farcomeni S, Negri DR, Cafaro A, Ensoli B, Titti F.
    Arch Virol; 2008 Oct 24; 153(3):463-72. PubMed ID: 18080858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.